baber/WOPTO huggingface dataset:
Patent AU-2020204707-A1 (AU)
Title: Battery enabled pellet grill
Inventor: GAFFORD ALEX
IPC: F24B13/04
Filed: 2020-01-03
Abstract: A system includes a cooking chamber defining a space for food to be cooked, a firepot inside the cooking chamber that is configured to utilize pelletized fuel to provide heat or smoke within the cooking chamber for cooking the food, and a fuel hopper defining a storage space for the pelletized fuel before delivery to the firepot. A battery powered auger interposes the fuel hopper and the firepot and is configured to selectively convey the pelletized fuel from the fuel hopper to the firepot for combustion. A rechargeable battery selectively provides power to the auger.
Patent AU-2020210256-A1 (AU)
Title: Solar Roof Panel
Inventor: RYAN BRAD
IPC: E04D13/18
Filed: 2020-07-30
Abstract: The present invention provides a solar roof panel 3 including a photoelectric cell 
assembly for converting solar energy into electrical energy, and a support assembly for 
5 the photoelectric cell assembly 19, 28, 31, 33. The support assembly includes (i) a 
sheet substrate 21 that has oppositely facing surfaces, with one surface having a flat 
surface on which the photoelectric cell assembly is mounted, and (ii) reinforcement 
members 27, 29 on the other surface of the substrate that stiffen the support assembly 
and are formed to facilitate locating the solar roof panel on the roof.  
10658822_1 (GHMatter) P93848.AU.2
5/134 
m 
r-
cC.J
Patent AU-2020214477-A1 (AU)
Title: Immunomodulator
Inventor: LI JIN
IPC: C07D411/14
Filed: 2020-01-21
Abstract: The present application discloses an immunomodulator, and specifically discloses a compound depicted by formula (I), or a stereoisomer thereof, or a pharmaceutically acceptable salt thereof. The compound provided in the present application can bind effectively to STING and has a good agonistic action on STING protein, and exhibits a good inhibitory effect on multiple tumors. Thus, the compound provided in the present application serves as a STING agonist and can be used for treating various related conditions. The compound provided in the present invention shows a very promising prospect for application thereof in the preparation of a medicament for treating a disease associated with STING activity (in particular, a medicament for treating an inflammatory disease, an allergic disease, an autoimmune disease, an infectious disease, a cancer or a precancerous syndrome) and in the preparation of an immune adjuvant, providing a novel option for clinically screening and/or preparing drugs for diseases associated with STING activity.
Patent AU-2020233642-A1 (AU)
Title: Methods of treating cancers using PD-1 axis binding antagonists and taxanes
Inventor: KIM JEONG
IPC: C07K16/28
Filed: 2020-09-15
Abstract: The invention provides methods and compositions for treating cancer and for enhancing immune 
function in an individual having cancer. The methods comprise administering a PD-1 axis binding 
antagonist and a taxane.  
5
Patent AU-2020244376-A1 (AU)
Title: A fully-human T cell receptor specific for the 369-377 epitope derived from the HER2/Neu (ERBB2) receptor protein
Inventor: POWELL JR DANIEL J
IPC: C07K14/705
Filed: 2020-09-28
Abstract: The present invention relates to compositions and methods for treating 
HER2/Neu (ERBB2) expressing cancer cells. In some embodiments, the invention 
includes an isolated T cell receptor (TCR) having high affinity for and that specifically 
5 binds ERBB2369-377 epitope on a target cell. Other embodiments include a T cell or a 
population of T cells modified to express ERBB2-specific TCR. Further embodiments 
include methods of using ERBB2-specific TCR gene transfer for treating ERBB2 
expressing cancer cells. Also included are methods and pharmaceutical compositions 
comprising the modified T cells for adoptive therapy.
Patent AU-2020250265-A1 (AU)
Title: Anaerobic blood storage containers
Inventor: YOSHIDA TATSURO
IPC: A61J1/05
Filed: 2020-10-08
Abstract: A blood storage device for storing oxygen depleted blood is disclosed. The blood storage 
device comprises an outer receptacle substantially impermeable to oxygen; a collapsible 
blood container; at least one inlet/outlet passing through said outer receptacle and that is in 
5 fluid communication with said collapsible container and that is substantially impermeable to 
oxygen; and an oxygen sorbent situated within said outer receptacle. At least one inlet/outlet 
comprises a unitary tube that is substantially impermeable to oxygen comprising bond, and 
tubing. The unitary tube is a barrier traversing tube that comprises an outer layer, an inner 
layer, and an oxygen barrier layer.  
0 Figure 1A
1/19 
20 
203 
201 
202 ... 215 
40 AAOAO~naOOAOAAOAOO .213 
207 
205 
FIG.304 
304 
30 
FIG. 1A
Patent AU-2020296163-A1 (AU)
Title: Aqueous agrochemical formulations comprising bacterial spores
Inventor: MALANG ULRIKE
IPC: A01N63/00
Filed: 2020-06-08
Abstract: Process for making liquid dispersion formulations comprising a) At least one type of bacterium spores, b) An aqueous continuous phase comprising at least one glycol, wherein said glycol is comprised in the formulation in a weight amount that exceeds the weight amount of water, c) optionally at least one surface active compound S, and d) Optionally further auxiliaries, B. Providing a solid powder of Bacterium spores, B1. Dispersing said spores in a continuous phase comprising at least one glycol, wherein the weight ratio of said at least one glycol to water is below or equal to 1:1, B2. Adding further glycol to the dispersion obtained in step B1. to obtain a ratio of said at least one glycol to water from 4:1 to 1.2 : 1, C. Adding at least one surfactant S, D. Optionally adding at least one thickener, E. Optionally adding further auxiliaries, Wherein steps C), D) and E) can be carried out at any time during the process.
Patent AU-2020297166-A1 (AU)
Title: Method for treating malignant tumor
Inventor: KOBA KAZUO
IPC: A61K31/5365
Filed: 2020-06-19
Abstract: A method for treating a malignant tumor in a human patient, said method comprising dosing a patient requiring the treatment with trans-3-amino-1-methyl-3-(4-(3-phenyl-5H-imidazo[1,2-c]pyrido[3,4-e][1,3]oxazin-2-yl)phenyl)cyclobutanol (compound 1) or a salt thereof in accordance with a dosing schedule, wherein the dosing schedule includes the administration of compound 1 or a salt thereof in a dose of 4-160 mg/body/day, in terms of compound 1, for 4 consecutive days followed by a specified drug holiday for 3 days.
Patent AU-2020299992-A1 (AU)
Title: Modulators of the NMDA receptor
Inventor: KILBURN JOHN PAUL
IPC: A61K31/4365
Filed: 2020-07-01
Abstract: The present invention is directed to novel modulators of the NMDA receptor. Separate aspects of the inventions are directed to pharmaceutical compositions comprising said compounds and uses of the compounds to treat neurological disorders or neuropsychiatric disorders such as depression.
Patent AU-2020316076-A1 (AU)
Title: Positioning a camera for perspective sharing of a surgical site
Inventor: MORVAN YANNICK
IPC: A61B34/20
Filed: 2020-07-23
Abstract: Techniques for augmenting a view of a first user of a first mixed reality (MR) visualization device in an operating room are described. For example, an intraoperative guidance system is configured to determine a location for a second user to stand within the operating room. A second MR visualization device is configured to be worn by the second user. The second MR visualization device is further configured to present a MR visualization that indicates the location for the second user to stand within the operating room. The first MR visualization device is configured to present a MR visualization that contains a window that show images of a surgical site captured by a camera supported by the second user.
Patent AU-2020317501-A1 (AU)
Title: Agent for regulating female hormone secretion and agent for alleviating unpleasant symptoms
Inventor: SAWADA DAISUKE
IPC: A61P17/10
Filed: 2020-07-17
Abstract: [Problem] The purpose of the present invention is to provide a novel technology capable of regulating female hormone secretion. [Solution] Provided is an agent for regulating female hormone secretion, which contains the lactobacillus strain Lactobacillus gasseri strain CP2305 (accession No.: FERM PB-11331), a treated product of said lactobacillus strain, or extracts thereof.
Patent AU-2020318697-A1 (AU)
Title: N-methyl, N-(6-(methoxy)pyridazin-3-yl) amine derivatives as autotaxin (ATX) modulators for the treatment of inflammatory airway or fibrotic diseases
Inventor: KUTTRUFF CHRISTIAN ANDREAS
IPC: C07D401/14
Filed: 2020-07-21
Abstract: The present invention relates to N-methyl, N-(6-(methoxy)pyridazin-3- yl) amine derivatives as autotaxin (ATX) modulators for the treatment of inflammatory airway or fibrotic diseases such as e.g. idiopathic lung disease (IFF) or systemic sclerosis (SSc). The present description discloses the preparation of exemplary compounds (e.g. pages 37 to 45; examples 1.1 to 1.13) as well as relevant biological data thereof (e.g. pages 12 to 17, tables 1 to 9). An exemplary compound is e.g. l-[4-(4-{l-[(6-{[6-(trifluoromethyl) pyridin-3-yl]methoxy}pyridazin-3-yl)amino]cyclopropyl}-phenyl) piperazin-l-yl]ethan-l-one (example 1.1).
Patent AU-2020323943-A1 (AU)
Title: Rotated concrete volume determination
Inventor: ROBERTS MARK F
IPC: G01N22/00
Filed: 2020-07-30
Abstract: Disclosed is a method for determining volume of a concrete mix load in a mixer drum based on use of an in-and-out sensor probe which submerges into and exits from the concrete during drum rotation and which provides data to a processor used for calculating volume based on the data. To provide for concavity, convexity, and/or cascading surface flow effects that can hinder accurate determination of the concrete load volume, the processor may be configured to compare original batch volume and/or rheology of the concrete load monitored during drum rotation. The calibration of load volume value, highly useful for monitoring or admixture dosing purposes, can be done based on comparison of real-time data with historic data gathered over time and stored in processor-accessible memory. Further exemplary embodiments also take into account the speed and/or tilt of the drum (due to roadway conditions), concrete mix design, and other factors.
Patent AU-2020325777-A1 (AU)
Title: Method for preparing a metal powder for an additive manufacturing process, and use of such a powder
Inventor: BUCHER SÉBASTIEN
IPC: B01J13/04
Filed: 2020-07-31
Abstract: The present invention concerns a method for preparing a metal powder for an additive manufacturing process involving the near-infrared laser beam sweeping of a powder bed, characterized in that the method comprises: an initial step of selecting a powder having an optical reflectivity of more than 70% for a wavelength in a range between 800 and 1500 nm; then a step of treating said powder, which is different from a grafting of particles and which induces physical and/or chemical surface modification of the particles (4) of said powder so as to reduce its optical reflectivity at the given wavelength. The invention also concerns the use of such a powder, of which the particles (4) after treatment have a median particle size d50 of between 5 and 50 µm.
Patent AU-2020328985-A1 (AU)
Title: Continuous concentrate feeding equipment
Inventor: KUSUNOSE Kenta
IPC: F27D3/18
Filed: 2020-08-06
Abstract: A continuous ore feeding device (110) according to the present invention can continuously feed ore to a smelting furnace without interruption of ore feeding even during reception of ore, and has: a pressure regulation tank (2) that temporarily stores powdered ore; a lift tank (6) that receives the ore from the pressure regulation tank (2) and discharges the ore to the smelting furnace; an air path (14) through which compressed air is introduced to the pressure regulation tank (2) and the lift tank (6); and a control means (28) for the compressed air, wherein the control means (28) causes the ore to be continuously fed from the lift tank (6) to the smelting furnace even during reception of the ore at the lift tank (6) from the pressure regulation tank (2).
Patent AU-2020342525-A1 (AU)
Title: Incubator with air curtain
Inventor: ROTHENBERG BARRY E
IPC: C12M1/26
Filed: 2020-09-03
Abstract: An incubator for cell and tissue culture under controlled atmospheric conditions has a primary air flow control device that forms a primary, preferably laminar flow, air veil across an opening that allows access to the cells or tissue cultures disposed within the incubator. Preferably, most if not all of the air in the primary (laminar flow) air veil is recirculated, and a secondary air flow control device is used that forms a secondary, preferably laminar flow, air veil between the primary (laminar flow) air veil and a user of the incubator.
Patent AU-2020354926-A1 (AU)
Title: Decoded picture buffer operation for resolution changes
Inventor: WANG YE-KUI
IPC: H04N19/70
Filed: 2020-09-17
Abstract: A video coding mechanism is disclosed. The mechanism includes receiving a bitstream comprising a plurality of pictures. A no output of prior pictures flag (NoOutputOfPriorPicsFlag) is set when a value of maximum picture width in luma samples (PicWidthMaxInSamplesY) for a current access unit (AU) is different from a value of PicWidthMaxInSamplesY for a preceding AU in decoding order. A decoded picture buffer (DPB) is emptied without output of contained pictures based on a value of the NoOutputOfPriorPicsFlag. A current picture is decoded and stored in the DPB. The current picture is output from the DPB for display as part of a decoded video sequence.
Patent AU-2020363437-A1 (AU)
Title: Expression of nitrogenase polypeptides in plant cells
Inventor: JOHNSTON EMA JAYNE
IPC: C12N9/10
Filed: 2020-10-09
Abstract: The present invention relates to methods and means for producing nitrogenase polypeptides in the mitochondria of plant cells.
Patent AU-2020365435-A1 (AU)
Title: Safe test arrangement
Inventor: NUSSBAUMER ROLAND
IPC: H04L12/423
Filed: 2020-10-16
Abstract: In order to provide a flexible test arrangement for performing measurements on a test object, according to the invention a plurality (n) of safety components (11,12,13) each having a safety module (M) which can be set to active or inactive mode and a ready state (r) which can be set to active or inactive mode are provided in a ring-like test arrangement, in which each of the safety components (11, 12, 13) carries out a number of function tests (T) cyclically, one of said function tests (T) involving testing cyclical error-free reception of a data packet (DP). One of the safety components (1, 11, 12, 13) is selected as a bus master (BM) which cyclically transmits a bus checking signal (B) in a data packet (DP1) to the next safety component (11, 12, 13) provided in the transmission direction, said bus checking signal (B) being relayed by each of the safety components (11, 12, 13) in a data packet (DP2, DP3), and, when said bus checking signal (B) is received in a data packet (DP3). the bus master (BM) identifies a closed ring-like test arrangement.
Patent AU-2020373899-A1 (AU)
Title: Drug for treating cancer, combination drug, drug composition, immune responsive cell, nucleic acid delivery vehicle, and product
Inventor: TAMADA KOJI
IPC: A61K39/395
Filed: 2020-10-28
Abstract: An example of the combination drug of the present invention, which is to be used for treating caner in a target, comprises (a1) an immune responsive cell expressing a cell-surface molecule specifically recognizing a cancer antigen, interleukin 7 and CCL19, or (a2) one or more kinds of cells or nucleic acid delivery vehicles cooperatively containing a nucleic acid encoding interleukin 7 and a nucleic acid encoding CCL19, or a combination thereof, and (b) an immunosuppression inhibitor. An example of the immune responsive cell expresses a cell-surface molecule specifically recognizing a cancer antigen, interleukin 7, CCL19 and an immunosuppression inhibitory polypeptide.
Patent AU-2020404580-A1 (AU)
Title: Improved genome editing using paired nickases
Inventor: D'HALLUIN KATELIJN
IPC: C12N15/82
Filed: 2020-12-07
Abstract: Genome editing including the introducing of precise gene edits is well established in diploid plants. Methods well established in the art introduce double strand DNA breaks in the genome of a plant applying technologies such as Zn-finger nucleases, homing endonucleases, TALEN or RNA guided nuclease e.g. Cas9 or Cas12a.
Patent AU-2020413304-A1 (AU)
Title: Anti-CDCP1 antibody
Inventor: HASHIMOTO SHUICHI
IPC: C07K16/46
Filed: 2020-12-24
Abstract: The purpose of the present invention is to provide: an anti-hCDCP1 antibody that can be used as an active ingredient in an anticancer agent or the like that has few side effects; and an ADC including the anti-hCDCP1 antibody. Specifically, the present invention is an antibody that binds to human CUB domain-containing protein 1 (CDCP1), and that is characterized by having low binding ability to human CD34-positive cells, or an antigen-binding fragment of said antibody. A representative example of the antibody is one that has a heavy chain CDR1 including the amino acid sequence represented by SEQ ID NO: 25, a heavy chain CDR2 including the amino acid sequence represented by SEQ ID NO: 26, a heavy chain CDR3 including the amino acid sequence represented by SEQ ID NO: 27, a light chain CDR1 including the amino acid sequence represented by SEQ ID NO: 29, a light chain CDR2 including the amino acid sequence represented by SEQ ID NO: 30, and a light chain CDR3 including the amino acid sequence represented by SEQ ID NO: 31.
Patent WO-2022032324-A1 (WO)
Inventor: GOULD ROD
IPC: A01K1/035
Filed: 2021-05-28
Abstract: The present invention relates to a portable shade and secure place for small to medium pets whilst out in the sun/public. The assembly includes a fold out concertina shade. When closed, the shade is a 'D' shape, and when opened, it represents an elongated 'dome' shape. The rear is a nylon material that is minimum 95% UV rated and the front section consists of a mesh material for ventilation. The front and rear sections connect via a zipper. There is a small zippered portal in the front section for the pet to access the shade. There is a removable padding in the bottom of the shade. There are 'D' rings front and rear to secure into the ground. The shade has an external pocket.
Patent AU-2021201189-A1 (AU)
Title: A pipe wear monitoring system and method of use thereof
Inventor: EAMES COLIN NEIL
IPC: G01B7/02
Filed: 2021-02-24
Abstract: (Figure 2) 
The present invention relates to a system and method for monitoring wear in pipes, particularly 
irregular wear in pipelines transporting abrasive fluids. The system includes a plurality of wear 
sensors spaced along a length of a pipe. Each wear sensor is configured to detect wear in a 
wall of the pipe. The system further includes at least one remotely accessible server operatively 
connected to the sensors for receiving and monitoring data output from said sensors. The server 
is configured to alert an operator when said data received from any one of the plurality of sensors 
is indicative of irregular wear in the wall of the pipe.
2/8 
C) 
C) 
C) 
C) 
CD 
U
co3 
C)C 
C) 
C) 
C1/ / 
C) 
C-
Patent AU-2021201733-A1 (AU)
Title: Simulator for telehandlers
Inventor: IOTTI MARCO
IPC: B66F17/00
Filed: 2021-03-19
Abstract: SIMULATOR FOR TELEHANDLERS 
ABSTRACT 
Described is a simulation system for telehandlers (1) equipped with a movable operating arm 
(12), designed to lift and move loads (C) and stabilisers, comprising a plurality of movable 
stabilising arms (13, 14, 15, 16), comprising electronic processing means (2) which include: 
an acquisition module (21) configured to receive at least functional parameters relating to 
operating conditions of the stabilising arms (13, 14, 15, 16); and 
a calculation module (24) configured for determining a potential stability condition, as a 
function of the operating parameters; and 
an output module (25) configured to provide an operator with information representing 
the condition of potential stability.  
[Figure 4]
4/5 
( -
Patent AU-2021221904-A1 (AU)
Title: Display substrate and display apparatus
Inventor: ZHANG DACHENG
IPC: H01L21/67
Filed: 2021-06-08
Abstract: A display substrate (10) and a display apparatus (30) are provided. The display substrate 
(10) includes a first conductive structure (110) including a first surface (111) and a third 
surface (113) that are opposite and a second surface (112) and a fourth surface (114) that are 
opposite, and the first surface and the second surface are made of a same material. The first 
surface (111) and the second surface (112) respectively have different angles with a plate 
surface of the base substrate (101). The first surface (111) is provided with a first surface 
microstructure (11), and the second surface (112) is provided with a second surface 
microstructure (12); the first surface microstructure (11) has a first cross section (11a) 
perpendicular to the base substrate (101), the first cross section (11) has a first orthogonal 
projection (C1C2) on the third surface (113), and a length of the first orthogonal projection 
(ClC2) is less than a length of the first surface microstructure (11) in the first cross section 
(1la); and the second surface microstructure (12) has a second cross section (12a) 
perpendicular to the base substrate (101), the second cross section (12a) has a second 
orthogonal projection (D1D2) on the fourth surface (114), and a length of the second 
orthogonal projection (D1D2) is less than a length of the second surface microstructure (12) 
in the second cross section (12a). The display substrate (10) can effectively increase the yield.
Patent AU-2021225617-A1 (AU)
Title: Functional human corneal endothelial cells and application thereof
Inventor: KINOSHITA SHIGERU
IPC: C12Q1/04
Filed: 2021-02-26
Abstract: The present invention provides cell trait assay techniques which identify cultured human corneal endothelial cells that, in a clinical trial, have been confirmed to express early-stage clinical effects and provide clinical effects that are stable in the long term. Provided is a method for producing functional human corneal endothelial cells which can bring about human corneal function when injected into the anterior chamber of a human eye, said method including a step for growing and/or differentiating/maturing corneal endothelium precursor cells under culturing conditions that can minimize culturing stress such as growth stress. Also provided are functional human corneal endothelial cells which have been found to express a functional protein leading to corneal endothelium (cell) functional characteristics that improve corneal clouding and hydration swelling, and, as a result, sustainably maintain corneal endothelium tissue cell density in the long term and lead to eyesight improvement, or in which proteins that inhibit such corneal endothelium (cell) functional characteristics are have not been elicited or are reduced.